Deferoxamine enhances anti-proliferative effect of interferon-γ against hepatocellular carcinoma cells

Cancer Letters

Volumn 248, Issue 1, 2007, Pages 24-31

  Okada, Toshie ^a   Sawada, Tokihiko ^a   Kubota, Keiichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Deferoxamine; Hepatocellular carcinoma; Insulin growth factor; Interferon ; Iron

Indexed keywords

CHELATING AGENT; DEFEROXAMINE MESYLATE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; MONOCLONAL ANTIBODY; SOMATOMEDIN C;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CHELATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DEFEROXAMINE; DRUG SYNERGISM; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; LIVER NEOPLASMS; RECEPTORS, INTERFERON; STAT1 TRANSCRIPTION FACTOR;

EID: 33847312841     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.05.014     Document Type: Article

References (22)

1. J. Ferlay, F. Bray, P. Pisani, D.M. Parkin, GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, version 1.0, IARC Press, Lyon, 2001.
2. Kiyosawa K., Umemura T., Ichijo T., Matsumoto A., Yoshizawa K., Gad A., and Tanaka E. Hepatocellular carcinoma: Trends in Japan. Gastroenterology 127 (2004) S17-S26
3. Pestka S., Kotenko S.V., Muthukumaran G., Izotova L.S., Cook J.R., and Garotta G. The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev. 8 (1997) 189-206
4. Levy D.E., and Darnell Jr. J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3 (2003) 651-662
5. Tomita Y., Bilim V., Hara N., Kasahara T., and Takahashi K. Role of IRF-1 and caspase-7 in IFN-gamma enhancement of Fas-mediated apoptosis in ACHN renal cell carcinoma cells. Int. J. Cancer 104 (2003) 400-408
6. Suyama T., Furuya M., Nishiyama M., Kasuya Y., Kimura S., Ichikawa T., Ueda T., Nikaido T., Ito H., and Ishikura H. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma. Cancer 103 (2005) 258-267
7. Valente G., Ozmen L., Novelli F., Geuna M., Palestro G., Forni G., and Garotta G. Distribution of interferon-gamma receptor in human tissues. Eur. J. Immunol. 22 (1992) 2403-2412
8. Bernabei P., Coccia E.M., Rigamonti L., Bosticardo M., Forni G., Pestka S., Krause C.D., Battistini A., and Novelli F. Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J. Leukoc. Biol. 70 (2001) 950-960
9. Allione A., Bernabei P., Bosticardo M., Ariotti S., Forni G., and Novelli F. Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis. J. Immunol. 163 (1999) 4182-4191
10. Bosticardo M., Ariotti S., Losana G., Bernabei P., Forni G., and Novelli F. Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7/CD28 costimulation. Eur. J. Immunol. 31 (2001) 2829-2838
11. Regis G., Bosticardo M., Conti L., De Angelis S., Boselli D., Tomaino B., Bernabei P., Giovarelli M., and Novelli F. Iron regulates T lymphocyte sensitivity to the IFN-γ/STAT1 signaling pathway in vitro and in vivo. Blood 105 (2005) 3214-3221
12. Bach E.A., Szabo S.J., Dighe A.S., Ashkenazi A., Aguet M., Murphy K.M., and Schreiber R.D. Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science 270 (1995) 1215-1218
13. Yin D., Tamaki N., Parent A.D., and Zhang J.H. Insulin-like growth factor-1 decreased etoposide-induced apoptosis in glioma cells by increasing bcl-2 expression and decreasing CPP32 activity. Neurol. Res. 27 (2005) 27-35
14. Rasmuson T., Grankvist K., Jacobsen J., Olsson T., and Ljungberg B. Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma. Acta Oncol. 43 (2004) 744-748
15. Bauer T.W., Fan F., Liu W., Johnson M., Parikh N.U., Parry G.C., Callahan J., Mazar A.P., Gallick G.E., and Ellis L.M. Insulin-like growth factor-1-mediated migration and invasion of human colon carcinoma cells requires activation of c-met and urokinase plasminogen activator receptor. Ann. Surg. 241 (2005) 748-758
16. Bernabei P., Bosticardo M., Losana G., Regis G., Di Paola F., De Angelis S., Giovarelli M., and Novelli F. IGF-1 down-regulates IFN-γR2 chain surface expression and desensitizes IFN-γ/STAT-1 signaling in human T lymphocytes. Blood 102 (2003) 2933-2939
17. Novelli F., Bernabei P., Ozmen L., Rigamonti L., Allione A., Pestka S., Garotta G., and Forni G. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-γ is correlated with the differential expression of the α- and β-chains of its receptor. J. Immunol. 157 (1996) 1935-1943
18. Rigamonti L., Ariotti S., Losana G., Gradini R., Russo M.A., Jouanguy E., Casanova J.L., Forni G., and Novelli F. Surface expression of the IFN-γR2 chain is regulated by intracellular trafficking in human T lymphocytes. J. Immunol. 164 (2000) 201-207
19. Richardson D.R. Iron chelation as therapeutic agents for the treatment of cancer. Crit. Rev. Oncol. Hematol. 42 (2002) 267-281
20. Buss J.L., Torti F.M., and Torti S.V. The role of iron chelation in cancer therapy. Curr. Med. Chem. 10 (2003) 1021-1034
21. Kim P.K., Armstrong M., Lui Y., Yan P., Bucher B., Zuckerbraun B.S., Gambotto A., Billiar T.R., and Yim J.H. IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo. Oncogene 23 (2004) 1125-1135
22. Porta C., Hadj-Slimane R., Nejmeddine M., Pampin M., Tovey M.G., Espert L., Alvarez S., and Chelbi-Alix M.K. Interferons α and γ induce p53-dependent and p53-independent apoptosis, respectively. Oncogene 24 (2005) 605-615